Kelvin is a PhD Student in the Biological and Biomedical Sciences (BBS) program at Harvard Medical School, jointly advised by Eric Sun and Vadim Gladyshev. He is broadly interested in integrating multiscale biological data and generative AI to understand and intervene in the aging process. Kelvin received his B.A. in molecular biology and data science from UC Berkeley in 2023. He then joined Zinaida Good and Crystal Mackall’s labs at Stanford University, where he uses computational immunology and AI/ML to engineer next-generation T cell therapies for cancer. Kelvin has held research positions at Genentech, Novartis, Intel, and Scripps. Outside of work, Kelvin can be found competing in intramural sports leagues, having hotpot with friends, and playing with his cat.
Sun Lab